Emadine en es it fr

Emadine Brand names, Emadine Analogs

Emadine Brand Names Mixture

  • No information avaliable

Emadine Chemical_Formula


Emadine RX_link


Emadine fda sheet

Emadine FDA

Emadine msds (material safety sheet)

Emadine Synthesis Reference

No information avaliable

Emadine Molecular Weight

393.436 g/mol

Emadine Melting Point

No information avaliable

Emadine H2O Solubility

Very slightly soluble (hydrochloride salt - maximal solubility of approximately 0.4 mg/mL occurs at a pH of approximately 2)

Emadine State


Emadine LogP


Emadine Dosage Forms

Tablet (27.3 mg, 109.3 mg or 163.9 mg)

Emadine Indication

For the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Also for use, in combination with gemcitabine, as the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Emadine Pharmacology

Erlotinib is a Human Epidermal Growth Factor Receptor Type 1/Epidermal Growth Factor Receptor (HER1/EGFR) tyrosine kinase inhibitor.

Emadine Absorption

Erlotinib is about 60% absorbed after oral administration and its bioavailability is substantially increased by food to almost 100%.

Emadine side effects and Toxicity

Symptoms of overdose include diarrhea, rash, and liver transaminase elevation.

Emadine Patient Information

Emadine Organisms Affected

Humans and other mammals